Sovenyr
Get early access
Signal
2026-07-13
ClinicalTrials.gov
[NA] High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)
Part of
Cancer-Induced Muscle Circadian Disruption
Open primary source
See the whole picture